Stanoil – Stanozolol (Winstrol) 100 mg/mL | Omega Lab
1. Product Overview
Stanoil is presented as an injectable stanozolol product associated with Omega Lab.
According to Roidsdeal and Finest Gears, the product contains stanozolol at a declared concentration of 100 mg/mL.
However, the supplied sources disagree on two important specifications. Roidsdeal describes a water-based preparation available in a 10–20 mL presentation, while Finest Gears identifies an oil-based preparation supplied in a 10 mL vial.
These differences require manufacturer verification before the product can be accurately characterized.
Stanozolol is a synthetic anabolic-androgenic steroid derived from dihydrotestosterone (DHT).
The name Winstrol is historically associated with pharmaceutical stanozolol products. Its inclusion in the title does not establish that Omega Lab Stanoil is an authorized Winstrol-branded medication.
The supplied descriptions promote muscle definition, conditioning, and pre-competition appearance. These are bodybuilding-related marketing claims rather than established medical indications.
2. What Is Stanoil?
Stanoil is described as an injectable preparation containing stanozolol.
Stanozolol is a synthetic DHT-derived anabolic-androgenic steroid with structural modifications that distinguish it from testosterone.
Unlike testosterone, stanozolol does not undergo aromatization into estrogen.
However, this characteristic does not eliminate endocrine, cardiovascular, reproductive, or liver-related risks.
The exact formulation of Stanoil remains uncertain.
Roidsdeal identifies the product as water-based, while Finest Gears identifies it as oil-based.
These formulation types are not interchangeable. The exact carrier ingredients, physical dosage form, preservatives, and manufacturing specifications require verification.
3. How Does Stanozolol Work?
Stanozolol interacts with androgen receptors in muscle and other androgen-responsive tissues.
Its principal pharmacological characteristics include:
- Androgen Receptor Activation: Influences androgen-dependent gene expression and tissue functions.
- Anabolic Activity: Affects biological pathways associated with protein metabolism and tissue maintenance.
- DHT-Derived Structure: Stanozolol is chemically related to dihydrotestosterone.
- Non-Aromatizing Activity: It is not converted into estrogen through the aromatase enzyme.
- 17-Alpha-Alkylated Structure: Associated with particular concern for liver toxicity.
- Hormonal Suppression: Can suppress endogenous reproductive hormone production.
Non-aromatizing activity does not establish that stanozolol produces a stable hormonal environment or prevents adverse endocrine effects.
4. Medical Uses & Clinical Information
Historical Medical Use: Stanozolol has a history of pharmaceutical use in selected conditions, including hereditary angioedema.
Androgenic Pharmacology: Its biological effects involve androgen receptor signaling and androgen-responsive tissue functions.
Protein Metabolism: Stanozolol can influence pathways associated with protein synthesis and nitrogen metabolism.
Performance Claims: Roidsdeal promotes muscle definition, conditioning, muscle density, and pre-competition appearance. These are not established FDA-approved medical indications for Omega Lab Stanoil.
Regulatory Context: Stanozolol is classified as a Schedule III controlled anabolic steroid in the United States and is prohibited under WADA regulations.
No verified FDA authorization or official prescribing information has been supplied for this specific Omega Lab formulation.
5. Product Specifications & Packaging
| Specification | Details |
|---|---|
| Product Name | Stanoil / StanOil 100 |
| Listed Manufacturer | Omega Lab |
| Active Ingredient | Stanozolol |
| Historical Brand Reference | Winstrol — Authorization Unverified |
| Chemical Classification | Dihydrotestosterone Derivative |
| Declared Concentration | 100 mg/mL |
| Product Form | Injectable Preparation |
| Formulation Base | Oil-Based or Water-Based — Conflicting Sources |
| Physical Dosage Form | Solution or Suspension — Unverified |
| Package Size | 10 mL or 20 mL — Unverified |
| Total Content, 10 mL | 1,000 mg |
| Total Content, 20 mL | 2,000 mg |
| Specific Injection Route | Not Verified |
| Aromatization | Does Not Aromatize Into Estrogen |
| US Controlled Substance Status | Schedule III |
| WADA Status | Prohibited |
| Product-Specific FDA Approval | Not Established |
| Batch-Specific COA | Not Provided |
| Sterility Documentation | Not Provided |
The supplied sources agree on the active ingredient, listed manufacturer, and concentration.
However, the formulation base and package size are inconsistent.
The actual available vial sizes, carrier ingredients, physical dosage form, and manufacturing specifications remain unverified.
6. Administration & Medical Supervision
Stanoil is described as an injectable preparation.
The declared concentration of 100 mg/mL is a product specification, not a recommended dose.
The supplied information does not establish the specific injection route, verified carrier ingredients, preservatives, or other formulation components.
The conflicting oil-based and water-based descriptions make manufacturer verification particularly important.
Stanozolol exposure can suppress natural reproductive hormone production and impair fertility.
Injectable preparations also introduce risks involving contamination, infection, and tissue injury.
No bodybuilding cycle, injection schedule, or performance-enhancement protocol is established by the available information.
7. Possible Side Effects & Safety Limitations
Potential adverse effects include:
- Acne, oily skin, and hair loss
- Increased facial or body hair
- Adverse cholesterol changes, including reduced HDL cholesterol
- Elevated blood pressure
- Cardiovascular complications
- Liver injury and cholestatic abnormalities
- Suppression of natural testosterone production
- Reduced sperm production and fertility disturbances
- Mood and behavioral changes
- Menstrual irregularities and virilization in females
- Injection-site inflammation or infection
Stanozolol is a 17-alpha-alkylated anabolic steroid, a structural characteristic associated with liver toxicity.
An injectable formulation does not eliminate liver-related risks.
Symptoms such as jaundice, dark urine, severe abdominal pain, chest pain, or serious injection-site inflammation require prompt medical evaluation.
8. Warnings & Precautions
Stanozolol is a Schedule III controlled anabolic steroid in the United States.
Individuals with liver disease, cardiovascular disease, hypertension, abnormal cholesterol levels, or endocrine disorders may face additional complications.
Stanozolol exposure can suppress reproductive hormone production and negatively affect fertility.
Exposure during pregnancy may cause fetal harm.
The Roidsdeal description presents Stanoil as a high-purity product suitable for advanced conditioning and pre-competition programs.
These claims do not establish verified pharmaceutical quality, safety, or approved therapeutic benefits.
Combining anabolic steroids or other potentially hepatotoxic substances may increase adverse-effect risks.
9. Storage & Handling
Stanoil is described as an injectable preparation, but the supplied sources disagree on its formulation base and package volume.
Verified manufacturer storage temperatures, stability data, sterility documentation, and expiration requirements have not been supplied.
Oil-based and water-based injectable formulations may have different pharmaceutical stability and handling characteristics.
The physical dosage form also requires confirmation.
A sealed vial does not independently establish sterility or correct ingredient identity.
Authentic manufacturer documentation is necessary to determine appropriate storage and handling requirements.
10. Frequently Asked Questions (FAQs)
Q1: What is Stanoil?
Stanoil is described as an injectable stanozolol product associated with Omega Lab.
Q2: What is the declared concentration?
Both Roidsdeal and Finest Gears identify 100 mg/mL.
Q3: Is Stanoil oil-based or water-based?
Finest Gears identifies an oil-based preparation, while Roidsdeal describes a water-based formulation. The correct composition remains unverified.
Q4: What vial sizes are available?
Finest Gears identifies 10 mL, while Roidsdeal lists 10–20 mL. Actual available package sizes require manufacturer confirmation.
Q5: Does stanozolol convert into estrogen?
Stanozolol does not undergo aromatization into estrogen. However, it can still cause significant endocrine, cardiovascular, reproductive, and liver-related adverse effects.
11. Conclusion & Medical Disclaimer
Stanoil is presented as a Stanozolol 100 mg/mL injectable product associated with Omega Lab.
The supplied sources agree on the active ingredient and concentration but disagree on the formulation base and package volume.
The exact composition, available vial sizes, Winstrol brand association, sterility, manufacturing quality, and regulatory authorization remain unverified.
Medical Disclaimer: This information is provided for educational and product-identification purposes only. It does not constitute medical advice, injection instructions, dosing guidance, or a recommendation for nonmedical anabolic steroid use.



